Defining and Measuring the Scope of Atopic Dermatitis

被引：4

作者：

Laird, Mary ^{[1
]}

Lo Sicco, Kristen ^{[1
]}

机构：

[1] NYU, Langone Hlth, Ronald O Perelman Dept Dermatol, New York, NY 10003 USA

来源：

MANAGEMENT OF ATOPIC DERMATITIS: METHODS AND CHALLENGES | 2017年 / 1027卷

关键词：

Comorbidities; Diagnosis; Diagnostic criteria; Disease severity; Quality of life; PARTY DIAGNOSTIC-CRITERIA; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; MINOR CLINICAL-FEATURES; FOOD ALLERGY; EARLY-CHILDHOOD; CONTACT-DERMATITIS; RISK-FACTOR; ECZEMA; MANAGEMENT; CHILDREN;

D O I：

10.1007/978-3-319-64804-0_9

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Atopic dermatitis (AD) has no definitive diagnostic test and has a large range of phenotypes, making it a difficult disease to assess and define. However, an agreed-upon definition of AD is important for clinical trials, population-based studies, and clinical practice. Several diagnostic criteria systems have been proposed to fill these needs, with none considered the gold standard. To further aid in standardized assessment of AD patients, numerous disease severity and quality of life measurement tools have been proposed. There is similarly no gold standard and efforts are ongoing to develop a single consensus scale. Finally, assessment of AD-associated comorbidities, including allergic/immunologic conditions, psychiatric disorders, and metabolic/cardiac conditions, is important when evaluating this patient population.

引用

页码：93 / 104

页数：12